PHIA Koninklijke Philips N.V.

Philips extends company’s mobile C-arm portfolio with Zenition 10

Philips extends company’s mobile C-arm portfolio with Zenition 10

May 2, 2023

  • New cost-effective addition to Philips Image Guided Therapy Mobile C-arm platform brings flat panel imaging and ease-of-use to routine surgery
  • Unique user profiles, application-specific protocols and high range of movement enhance the operating room staff experience and contribute to improved patient outcomes

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of , a new addition to the company’s Zenition mobile C-arm series. Based on Philips’ state-of-the-art flat panel detector technology, Zenition 10 helps to expand patient access to routine surgical care and minimally invasive procedures. Now commercially available [1], the cost-effective, high-utilization, high-image-quality mobile C-arm enables surgeons to treat more patients at a lower cost while helping improve patient outcomes.

“Philips Zenition mobile C-arms have long been recognized for their high-quality imaging and efficiency-enhancing performance. With the introduction of Zenition 10, we are making those benefits available on a C-arm that meets the wide-ranging needs of routine open and minimally invasive surgery, allowing more patients in more parts of the world to receive the high-quality care,” said Mark Stoffels, General Manager, Image Guided Therapy Systems at Philips.

Mitigating staff shortages, increasing access to high-quality care

To help alleviate operating room staff shortages and rising healthcare costs, Philips Zenition 10 provides a cost-effective imaging solution for routine surgery, delivers the speed and efficiency needed to deal with high patient throughput, while being flexible enough to meet the needs of orthopedics, trauma, and other areas of surgery to maximize utilization. It comes with exceptional C-arm maneuverability, application-specific protocols, and personalized user profiles. At the same time, it delivers the excellent image quality needed to improve patient outcomes. User-friendly and intuitive to operate, the Zenition 10 supports a fast learning curve and reduces operating staff training time. Next to this, the new system offers a dedicated low-dose pediatric mode.

Consistent image quality is facilitated by application-specific protocols, customizable presets, and unique user profiles that automatically adjust Zenition 10 settings to suit an individual user’s preferences whenever they log in. An uninterruptible power supply allows the unit to be moved from one operating room to another without the need to reboot the entire system. Its excellent C-arm geometry provides the maneuverability needed for operating room staff to access target anatomies. Philips BodySmart facilitates dose efficiency by automatically

adapting the measuring field to the area of interest.

For images of patients with metal implants, Philips MetalSmart software automatically enhances image quality and dose efficiency. A dedicated pediatric mode automatically reduces dose rates for young patients. The system's digital subtraction angiography capability further enhances the range of surgical procedures facilitated by the Zenition 10, allowing clear imaging of vasculatures.

The Zenition mobile C-arm platform brings together innovations in image capture, image processing, ease-of-use, and versatility pioneered on Philips’ highly successful and Windows® based Zenition platform. Other C-arm systems in Philips’ Zenition series are the and .

[1] Zenition 10 mobile C-arm systems are available for sale in a limited number of countries. Please check with a local representative for availability in your market.





For further information, please contact:

Joost Maltha 

Philips Global Press Office 

Tel: +31 6 10 55 8116  

Email: 

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments



EN
02/05/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips receives FDA 510(k) clearance for Verida, the world’s first AI...

Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications April 16, 2026 Combining always-on spectral imaging with AI reconstruction to deliver enhanced levels of image quality, efficiency, and clinical insight across radiology, cardiology, and oncology Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received U.S. Food and Drug Administration 510(k) clearance for the system, bringing its next-generation, AI-powere...

 PRESS RELEASE

MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new...

MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member April 2, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Carla Goulart Peron, MD, Chief Medical Officer at Philips, has been appointed to the of the Medical Device Innovation Consortium (). Founded in 2012, MDIC is a unique public-private partnership that brings stakeholders across the medical device spectrum together with the US Food and Drug Administration () and other agency partners to help ensure patient access to medical device inn...

 PRESS RELEASE

FDA clears Philips AI solution that provides real-time guidance during...

FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair March 26, 2026 Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive procedures, supporting treatment [2]DeviceGuide integrates with Philips Azurion image-guided therapy platform that combines imaging, real-time data and intelligent software within a unified workflow to support more consistent, efficient and confidently guided minimally invasive procedures Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA...

 PRESS RELEASE

Philips launches IntraSight Plus to simplify coronary interventions an...

Philips launches IntraSight Plus to simplify coronary interventions and advance precision care March 25, 2026 Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient careWith FDA clearance and CE marking, IntraSight Plus streamlines the workflow efficiency of minimally invasive coronary procedures and can enable system operation time savings up to 47% in both the USA and Europe Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technolog...

 PRESS RELEASE

Philips remains No. 1 in Medtech at European Patent Office and the lar...

Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant March 24, 2026 Philips ranks No. 1 among medical technology companies in the European Patent Office Technology Dashboard 2025, filing 1,289 patent applications with the EPO in 2025.Philips’ platform-based solutions integrate hardware, software, data and AI to address clinical, operational and everyday health challenges.Philips’ innovation improved the lives of 2 billion people in 2025, with the goal of improving 2.5 billion lives per year by 2030, including 400 million people in medically unde...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch